Marinus H. J. van Oers

Amsterdam University Medical Centers — Netherlands

Medicine · Health Sciences

63h-index12.7kcitations280works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chronic Lymphocytic Leukemia Research(131), Lymphoma Diagnosis and Treatment(85), Immune Cell Function and Interaction(39), Viral-associated cancers and disorders(36), Immunodeficiency and Autoimmune Disorders(33)

Publications280 total

Prognosis of IGLV3-21R110 chronic lymphocytic leukemia after chemotherapy-based treatment in a real-world analysis
Leukemia·2023Open Access
Supplementary Figure 1 from Tipping the Noxa/Mcl-1 Balance Overcomes ABT-737 Resistance in Chronic Lymphocytic Leukemia
2023Open Access
Data from Tipping the Noxa/Mcl-1 Balance Overcomes ABT-737 Resistance in Chronic Lymphocytic Leukemia
2023Open Access
Supplementary Figure 4 from Tipping the Noxa/Mcl-1 Balance Overcomes ABT-737 Resistance in Chronic Lymphocytic Leukemia
2023Open Access
Data from Tipping the Noxa/Mcl-1 Balance Overcomes ABT-737 Resistance in Chronic Lymphocytic Leukemia
2023Open Access
Supplementary Figure 4 from Tipping the Noxa/Mcl-1 Balance Overcomes ABT-737 Resistance in Chronic Lymphocytic Leukemia
2023Open Access
Supplementary Figure 2 from Tipping the Noxa/Mcl-1 Balance Overcomes ABT-737 Resistance in Chronic Lymphocytic Leukemia
2023Open Access
Supplementary Figure 5 from Tipping the Noxa/Mcl-1 Balance Overcomes ABT-737 Resistance in Chronic Lymphocytic Leukemia
2023Open Access
Supplementary Figure 2 from Tipping the Noxa/Mcl-1 Balance Overcomes ABT-737 Resistance in Chronic Lymphocytic Leukemia
2023Open Access
Supplementary Figure 3 from Tipping the Noxa/Mcl-1 Balance Overcomes ABT-737 Resistance in Chronic Lymphocytic Leukemia
2023Open Access
Supplementary Figure 5 from Tipping the Noxa/Mcl-1 Balance Overcomes ABT-737 Resistance in Chronic Lymphocytic Leukemia
2023Open Access
Supplementary Figure 1 from Tipping the Noxa/Mcl-1 Balance Overcomes ABT-737 Resistance in Chronic Lymphocytic Leukemia
2023Open Access
Supplementary Figure 3 from Tipping the Noxa/Mcl-1 Balance Overcomes ABT-737 Resistance in Chronic Lymphocytic Leukemia
2023Open Access
Supplementary Table 2 from <i>In vivo</i> Dynamics of Stable Chronic Lymphocytic Leukemia Inversely Correlate with Somatic Hypermutation Levels and Suggest No Major Leukemic Turnover in Bone Marrow
2023Open Access
Supplementary Table 1 from <i>In vivo</i> Dynamics of Stable Chronic Lymphocytic Leukemia Inversely Correlate with Somatic Hypermutation Levels and Suggest No Major Leukemic Turnover in Bone Marrow
2023Open Access
Supplementary Table 1 from <i>In vivo</i> Dynamics of Stable Chronic Lymphocytic Leukemia Inversely Correlate with Somatic Hypermutation Levels and Suggest No Major Leukemic Turnover in Bone Marrow
2023Open Access
Supplementary Table 2 from <i>In vivo</i> Dynamics of Stable Chronic Lymphocytic Leukemia Inversely Correlate with Somatic Hypermutation Levels and Suggest No Major Leukemic Turnover in Bone Marrow
2023Open Access
Data from <i>In vivo</i> Dynamics of Stable Chronic Lymphocytic Leukemia Inversely Correlate with Somatic Hypermutation Levels and Suggest No Major Leukemic Turnover in Bone Marrow
2023Open Access
Data from <i>In vivo</i> Dynamics of Stable Chronic Lymphocytic Leukemia Inversely Correlate with Somatic Hypermutation Levels and Suggest No Major Leukemic Turnover in Bone Marrow
2023Open Access
High Resolution Assessment of Minimal Residual Disease (MRD) By Next-Generation Sequencing (NGS) and High-Sensitivity Flow Cytometry (hsFCM) in the Phase 3 GAIA (CLL13) Trial
Blood·2021· 7 cited
page 1 of 14Next →

Frequent Co-authors

Eric Eldering(11), René A. W. van Lier(10), Arnon P. Kater(9), Steven T. Pals(6), Ramon Arens(6), Bronno van der Holt(6), Joke W. Baars(5), H M Lokhorst(5), Jan J. Cornelissen(5), Pieter Sonneveld(5), Edo Vellenga(5), Anton Hagenbeek(4), Kiki Tesselaar(4), Leo F. Verdonck(4), M Schaafsma(4), Frank Miedema(4), Annelieke Jaspers(4), Henk M. Lokhorst(3), W.E. Fibbe(3), Harry C. Schouten(3)